ALGS
Price
$9.72
Change
+$0.36 (+3.85%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
65.06M
DYN
Price
$13.15
Change
+$0.57 (+4.53%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.79B
34 days until earnings call
Interact to see
Advertisement

ALGS vs DYN

Header iconALGS vs DYN Comparison
Open Charts ALGS vs DYNBanner chart's image
Aligos Therapeutics
Price$9.72
Change+$0.36 (+3.85%)
Volume$100
Capitalization65.06M
Dyne Therapeutics
Price$13.15
Change+$0.57 (+4.53%)
Volume$31.24K
Capitalization1.79B
ALGS vs DYN Comparison Chart in %
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. DYN commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Hold and DYN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ALGS: $9.72 vs. DYN: $13.15)
Brand notoriety: ALGS and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 53% vs. DYN: 27%
Market capitalization -- ALGS: $65.06M vs. DYN: $1.79B
ALGS [@Biotechnology] is valued at $65.06M. DYN’s [@Biotechnology] market capitalization is $1.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, ALGS is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 6 TA indicator(s) are bullish while DYN’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 6 bullish, 4 bearish.
  • DYN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than DYN.

Price Growth

ALGS (@Biotechnology) experienced а +0.52% price change this week, while DYN (@Biotechnology) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

DYN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.79B) has a higher market cap than ALGS($65.1M). DYN YTD gains are higher at: -46.604 vs. ALGS (-76.506). ALGS has higher annual earnings (EBITDA): -75.81M vs. DYN (-437.37M). DYN has more cash in the bank: 684M vs. ALGS (123M). ALGS has less debt than DYN: ALGS (6.88M) vs DYN (121M). ALGS has higher revenues than DYN: ALGS (3.17M) vs DYN (0).
ALGSDYNALGS / DYN
Capitalization65.1M1.79B4%
EBITDA-75.81M-437.37M17%
Gain YTD-76.506-46.604164%
P/E RatioN/AN/A-
Revenue3.17M0-
Total Cash123M684M18%
Total Debt6.88M121M6%
TECHNICAL ANALYSIS
Technical Analysis
ALGSDYN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAMUX22.03N/A
N/A
Cambiar SMID Institutional
NMPAX14.74-0.09
-0.61%
Columbia Mid Cap Index Inst
OTCJX32.57-0.21
-0.64%
MFS Mid Cap Growth R4
PGLRX18.31-0.12
-0.65%
Putnam Focused International Equity R
HSLTX47.85-0.46
-0.95%
Hartford Small Cap Growth R5

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with DYN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-12.93%
DYN - ALGS
40%
Loosely correlated
-4.48%
DSGN - ALGS
39%
Loosely correlated
-5.12%
BEAM - ALGS
38%
Loosely correlated
-2.12%
RXRX - ALGS
37%
Loosely correlated
-5.12%
XNCR - ALGS
37%
Loosely correlated
-1.34%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-4.48%
XNCR - DYN
58%
Loosely correlated
-1.34%
RNA - DYN
58%
Loosely correlated
-5.48%
CRNX - DYN
56%
Loosely correlated
+2.02%
IDYA - DYN
52%
Loosely correlated
+0.08%
SYRE - DYN
52%
Loosely correlated
-8.18%
More